We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$123M
AUM Growth
-$45.7M
Cap. Flow
-$44.3M
Cap. Flow %
-36.11%
Top 10 Hldgs %
29.13%
Holding
142
New
37
Increased
19
Reduced
19
Closed
34

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.21M
2
ACI icon
Albertsons Companies
ACI
+$3.18M
3
OSH
Oak Street Health, Inc.
OSH
+$2.89M
4
IMVT icon
Immunovant
IMVT
+$2.84M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$2.49M

Top Sells

Rank Stock Value
1
DELL icon
Dell
DELL
+$14.3M
2
MA icon
Mastercard
MA
+$12.9M
3
FISV
Fiserv Inc
FISV
+$8.83M
4
V icon
Visa
V
+$8.72M
5
MSDAU
MSD Acquisition Corp. Unit
MSDAU
+$5.05M

Sector Composition

Rank Sector Weight
1 Healthcare 67.14%
2 Technology 10.92%
3 Consumer Discretionary 4.92%
4 Financials 4.39%
5 Communication Services 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
$4.44M 3.62%
21,948
+15,500
+240% +$2.49M
IWD icon
2
iShares Russell 1000 Value ETF
IWD
$82.2B
$4.25M 3.46%
27,900
+4,075
+17% +$629K
CPNG icon
3
Coupang
CPNG
$29.3B
$4.1M 3.34%
256,264
– –
AXSM icon
4
Axsome Therapeutics
AXSM
$11.4B
$3.75M 3.05%
60,774
+5,650
+10% +$371K
OSH
5
DELISTED
Oak Street Health, Inc.
OSH
$3.46M 2.82%
+89,400
New +$2.89M
ATVI
6
DELISTED
Activision Blizzard
ATVI
$3.42M 2.79%
40,000
– –
ACI icon
7
Albertsons Companies
ACI
$5.61B
$3.2M 2.61%
+154,000
New +$3.18M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.17M 2.58%
+29,000
New +$3.21M
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
$3.03M 2.47%
347,786
-47,546
-12% -$381K
VMW
10
DELISTED
VMware, Inc
VMW
$2.95M 2.4%
23,600
– –
TVTX icon
11
Travere Therapeutics
TVTX
$5.22B
$2.74M 2.23%
121,834
– –
MLTX icon
12
MoonLake Immunotherapeutics
MLTX
$1.57B
$2.61M 2.13%
+122,201
New +$2.05M
APLS
13
DELISTED
Apellis Pharmaceuticals
APLS
$2.58M 2.1%
39,111
– –
IMVT icon
14
Immunovant
IMVT
$7.89B
$2.54M 2.07%
+163,799
New +$2.84M
TGNA
15
DELISTED
TEGNA Inc
TGNA
$2.44M 1.98%
144,000
– –
BKI
16
DELISTED
Black Knight, Inc. Common Stock
BKI
$2.43M 1.98%
42,200
– –
VRDN icon
17
Viridian Therapeutics
VRDN
$2.1B
$2.41M 1.97%
94,909
-5,073
-5% -$163K
FHN icon
18
First Horizon
FHN
$12.2B
$2.41M 1.96%
135,400
– –
ISEE
19
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.39M 1.94%
98,094
– –
RXDX
20
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$2.25M 1.83%
20,955
+1,679
+9% +$193K
RLAY icon
21
Relay Therapeutics
RLAY
$4.13B
$2.13M 1.73%
129,245
-47,276
-27% -$848K
COGT icon
22
Cogent Biosciences
COGT
$6.7B
$1.99M 1.62%
183,984
– –
XOMA
23
DELISTED
Xoma
XOMA
$1.97M 1.61%
+93,375
New +$1.96M
BCYC
24
Bicycle Therapeutics
BCYC
$269M
$1.97M 1.6%
92,434
– –
DICE
25
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$1.93M 1.57%
67,357
+28,293
+72% +$838K
1
2 3 4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return

HighVista Strategies's Q1 2023 Portfolio in Review

As of Q1 2023, HighVista Strategies held 142 positions worth $123M, down 27% from $168M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

HighVista Strategies withdrew a net $44.3M in Q1 2023, closing 34 positions and reducing 19 holdings. Its most notable exit was Dell, an estimated $14.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 47% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, HighVista Strategies opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $3.17M.

  • HighVista Strategies's largest Q1 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 29,000 shares worth $3.17M.
  • HighVista Strategies added most to Seagen Inc. Common Stock in Q1 2023, an estimated $2.49M increase.
  • HighVista Strategies's biggest Q1 2023 reduction was Mastercard, cutting an estimated $12.9M.
  • HighVista Strategies fully exited Dell in Q1 2023, selling an estimated $14.3M.
  • HighVista Strategies's ten largest holdings make up 29% of its $123M portfolio in Q1 2023.
  • HighVista Strategies opened 37 new positions and closed 34 in Q1 2023.
  • HighVista Strategies's portfolio value fell 27% quarter-over-quarter to $123M.

Based on HighVista Strategies's 13F filing for Q1 2023, filed 15 May 2023.